Diabetes Mellitus, Type 2 Clinical Trials in Berlin

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Birmingham, Alabama
  • +199 more
2021-10-14
Oct 14, 2021
N
Recruiting
  • Diabetes Mellitus, Type 2
  • Co-formulation NNC0480 0389+Semaglutide A 10/1 mg/mL
  • +3 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
2021-09-16
Sep 16, 2021
N
Recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Buena Park, California
  • +177 more
2021-09-08
Sep 8, 2021
R
Completed
  • Diabetes Mellitus, Type 2
  • Coronary Artery Disease
  • Bahía Blanca, Argentina
  • +213 more
2021-07-23
Jul 23, 2021
N
Recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Berlin, Germany
    Novo Nordisk Investigational Site
2021-05-18
May 18, 2021
N
Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • Berlin, Germany
    Novo Nordisk Investigational Site
2021-03-05
Mar 5, 2021
N
Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +236 more
2021-01-13
Jan 13, 2021
N
Completed
  • Diabetes Mellitus, Type 2
  • BYM338 10 mg/kg
  • Placebo
  • Anaheim, California
  • +8 more
2020-12-09
Dec 9, 2020
N
Completed
  • Diabetes Mellitus, Type 2
  • Buenos Aires, Santa Fe, Argentina
  • +186 more
2020-12-17
Dec 17, 2020
N
Completed
  • Diabetes Mellitus, Type 2
  • Renal Insufficiency
  • Buenos Aires, Argentina
  • +89 more
2020-12-11
Dec 11, 2020
G
Completed
  • Diabetes Mellitus, Type 2
  • Searcy, Arkansas
  • +157 more
2020-11-13
Nov 13, 2020
A
Completed
  • Diabetes Mellitus, Type 2
  • MEDI0382 low dose
  • +4 more
  • Birmingham, Alabama
  • +118 more
2020-07-31
Jul 31, 2020
T
Active, not recruiting
  • Ischemic Heart Disease Chronic
  • Diabetes Mellitus, Type 2
  • lifestyle intervention
  • usual care
  • Aachen, Germany
  • +9 more
2020-06-09
Jun 9, 2020
A
Completed
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
2020-03-04
Mar 4, 2020
B
N
Completed
  • Diabetes Mellitus, Type 2
  • Semaglutide 3 mg
  • +7 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
2019-11-13
Nov 13, 2019
E
Terminated
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +33 more
2019-09-25
Sep 25, 2019
E
Completed
  • Cardiovascular Disease
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +300 more
2019-09-18
Sep 18, 2019